Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland

K. J. Aaltonen, J. T. Joensuu, L. Pirilä, M. Kauppi, T. Uutela, T. Varjolahti-Lehtinen, T. Yli-Kerttula, P. Isomäki, D. Nordström, T. Sokka

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalScandinavian Journal of Rheumatology
Volume46
Issue number5
Pages (from-to)359-363
Number of pages5
ISSN0300-9742
DOIs
Publication statusPublished - 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • ANKYLOSING-SPONDYLITIS
  • PSORIATIC-ARTHRITIS
  • BIOLOGIC THERAPIES
  • SPONDYLOARTHRITIS
  • IMMUNOGENICITY
  • METAANALYSIS
  • PERSISTENCE
  • INFLIXIMAB
  • REGISTRY
  • 3121 Internal medicine
  • 317 Pharmacy

Cite this

Aaltonen, K. J. ; Joensuu, J. T. ; Pirilä, L. ; Kauppi, M. ; Uutela, T. ; Varjolahti-Lehtinen, T. ; Yli-Kerttula, T. ; Isomäki, P. ; Nordström, D. ; Sokka, T. / Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland. In: Scandinavian Journal of Rheumatology. 2017 ; Vol. 46, No. 5. pp. 359-363.
@article{9c7437165c7044b9ab2ab8e03f1806bc,
title = "Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland",
keywords = "ANKYLOSING-SPONDYLITIS, PSORIATIC-ARTHRITIS, BIOLOGIC THERAPIES, SPONDYLOARTHRITIS, IMMUNOGENICITY, METAANALYSIS, PERSISTENCE, INFLIXIMAB, REGISTRY, 3121 Internal medicine, 317 Pharmacy",
author = "Aaltonen, {K. J.} and Joensuu, {J. T.} and L. Piril{\"a} and M. Kauppi and T. Uutela and T. Varjolahti-Lehtinen and T. Yli-Kerttula and P. Isom{\"a}ki and D. Nordstr{\"o}m and T. Sokka",
year = "2017",
doi = "10.1080/03009742.2016.1234641",
language = "English",
volume = "46",
pages = "359--363",
journal = "Scandinavian Journal of Rheumatology",
issn = "0300-9742",
publisher = "TAYLOR & FRANCIS LTD",
number = "5",

}

Aaltonen, KJ, Joensuu, JT, Pirilä, L, Kauppi, M, Uutela, T, Varjolahti-Lehtinen, T, Yli-Kerttula, T, Isomäki, P, Nordström, D & Sokka, T 2017, 'Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland', Scandinavian Journal of Rheumatology, vol. 46, no. 5, pp. 359-363. https://doi.org/10.1080/03009742.2016.1234641

Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland. / Aaltonen, K. J.; Joensuu, J. T.; Pirilä, L.; Kauppi, M.; Uutela, T.; Varjolahti-Lehtinen, T.; Yli-Kerttula, T.; Isomäki, P.; Nordström, D.; Sokka, T.

In: Scandinavian Journal of Rheumatology, Vol. 46, No. 5, 2017, p. 359-363.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland

AU - Aaltonen, K. J.

AU - Joensuu, J. T.

AU - Pirilä, L.

AU - Kauppi, M.

AU - Uutela, T.

AU - Varjolahti-Lehtinen, T.

AU - Yli-Kerttula, T.

AU - Isomäki, P.

AU - Nordström, D.

AU - Sokka, T.

PY - 2017

Y1 - 2017

KW - ANKYLOSING-SPONDYLITIS

KW - PSORIATIC-ARTHRITIS

KW - BIOLOGIC THERAPIES

KW - SPONDYLOARTHRITIS

KW - IMMUNOGENICITY

KW - METAANALYSIS

KW - PERSISTENCE

KW - INFLIXIMAB

KW - REGISTRY

KW - 3121 Internal medicine

KW - 317 Pharmacy

U2 - 10.1080/03009742.2016.1234641

DO - 10.1080/03009742.2016.1234641

M3 - Article

VL - 46

SP - 359

EP - 363

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

SN - 0300-9742

IS - 5

ER -